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Abstract
Inflammasomes are multiprotein complexes nucleating around an NLR (Nucleotide-binding
domain and Leucine-rich Repeat containing protein), which regulate the secretion of the
pro-inflammatory interleukin (IL)-1β and IL-18 cytokines. Monocytes and macrophages, the
main cells expressing the inflammasome genes, adapt to their surrounding microenviron-
ment by a phenotypic polarization towards a pro-inflammatory M1 phenotype that promotes
inflammation or an anti-inflammatory M2 phenotype important for resolution of inflammation.
Despite the importance of inflammasomes in health and disease, little is known about
inflammasome gene expression in relevant human cells and the impact of monocyte and
macrophage polarization in inflammasome gene expression. We examined the expression
of several members of the NLR, caspase and cytokine family, and we studied the activation
of the well-described NLRP3 inflammasome in an experimental model of polarized human
primary monocytes and monocyte-derived macrophages (M1/M2 phenotypes) before and
after activation with LPS, a well-characterized microbial pattern used in inflammasome acti-
vation studies. Our results show that the differentiation of monocytes to macrophages alters
NLR expression. Polarization using IFN-γ (M1 phenotype), induces among the NLRs stud-
ied, only the expression of NOD2. One of the key results of our study is that the induction of
NLRP3 expression by LPS is inhibited in the presence of IL-4+IL-13 (M2 phenotype) at both
mRNA and protein level in monocytes and macrophages. Unlike caspase-3, the expression
of inflammasome-related CASP1 (encodes caspase-1) and CASP4 (encodes caspase-4) is
up-regulated in M1 but not in M2 cells. Interestingly, the presence of LPS marginally influ-
enced IL18 mRNA expression and secretion, unlike its impact on IL1B. Our data provide the
basis for a better understanding of the role of different inflammasomes within a given envi-
ronment (M1 and M2) in human cells and their impact in the pathophysiology of several
important inflammatory disorders.
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Introduction
Inflammation is characterized by increased cytokine secretion and activation of innate immu-
nity cells. In response to stimuli present in their local microenvironment or in circulation,
monocytes and macrophages modulate their gene expression towards either a pro-inflamma-
tory M1 or an anti-inflammatory M2 phenotype. M1 cells play an important role in host
defense through cytokine production, whereas M2 cells mediate tissue repair and homeostasis
[1–6]. This adaptation of monocytes and macrophages to their immediate microenvironment
is known as polarization and can occur at any time during inflammation [7]. However, the
impact of the polarization status in human pathophysiology and the related inflammatory sig-
naling remains poorly understood.
Innate response during inflammation is assured by the family of the evolutionarily con-
served NLR receptors (Nucleotide-binding domain and Leucine-rich Repeat containing pro-
teins) expressed mainly in monocytes and macrophages [8]. Upon detection of microbial
(Pathogen-associated molecular patterns, PAMPs) or cell damage molecular patterns (Dam-
age-associated molecular pattern, DAMPs), NLRs initiate the formation of multiprotein intra-
cellular complexes called inflammasomes, which regulate secretion of the bioactive forms of
the IL-1 cytokine family, through association with the adaptor protein ASC (Apoptosis-associ-
ated Speck-like protein containing a Caspase recruitment domain), and activation of caspase-1
(encoded by CASP1) [9–11]. The secreted IL-1β and IL-18 play key roles in systemic inflam-
mation promoting the expression of pro-inflammatory genes and thereby amplifying the
inflammatory response. NLRs are multi-domain proteins. Their C-terminal domain is rich in
leucine repeats (LRR), which under resting conditions, auto-inhibits the NLR [12,13]. The cen-
tral nucleotide-binding domain (NACHT), mediates oligomerization and a variable N-termi-
nal effector domain subdivides the NLR family into subgroups (S1 Fig) [14]. Among NLRs,
NLRP1 [15], NLRP2 [16], NLRP3 [16], NLRP6 [17], NLRP7 [18], NLRP12 [19], NLRC4 and
NLRB/NAIP [20] are considered as inflammasome-nucleating proteins. The NLRP3 inflam-
masome gained a lot of attention due to the causality of NLRP3 mutations in cryopyrin-associ-
ated periodic syndromes (CAPS) [21,22], an auto-inflammatory pathology characterized by
high levels of IL-1β secretion from peripheral blood mononuclear cells (PBMCs) of patients.
Inflammasomes are key regulators of pro-inflammatory cytokine secretion, and despite
their importance in several diseases and in host defense [10,11,23,24], the expression profile of
the assembling NLRs and inflammasome-related genes in human immune cells is still elusive.
Although mice have provided important insight into the understanding of the pathophysiol-
ogy of human diseases, important differences exist between species including differences in
innate immunity cells and sensitivity to LPS [25–27]. We undertook this study to examine the
links between the polarization status of monocytes and macrophages and the expression of key
molecules involved in inflammasome formation and activation in human-relevant primary
cells (PBMCs, M1 and M2 monocytes and macrophages). These data should open new lines of
research for a better understanding of the role of different inflammasomes at a given environ-
ment (M1 and M2) and their impact in the pathophysiology of several important inflamma-
tory diseases.
Materials and methods
Peripheral blood mononuclear cell, monocyte and macrophage isolation
Peripheral blood mononuclear cells were isolated from buffy coats provided by the “Etablisse-
ment Francais du Sang, (EFS)” from apparently healthy blood donors, using Ficoll density gra-
dient as described previously [28]. Monocytes were selected by 1h adherence and cultured for
NLR expression in polarized monocytes and macrophages
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24h in the presence of RPMI 1640 complemented with 10% pooled human serum (HS), peni-
cillin and streptomycin (complete medium). Monocyte-derived macrophages were obtained
after 7 days culture of monocytes in the presence of complete medium (named macrophages
from here after).
Monocyte and macrophage polarization
Monocytes after adherence or macrophages (after 7 days in culture) were treated either with 100
ng/ml interferon (IFN)-γ (to polarize towards an M1 phenotype) or with 10 ng/ml IL-4+IL-13
(to polarize towards an M2 phenotype) or with complete medium alone (control cells, M0) for
24h. The last 3h, cells were treated with 100 ng/ml LPS. Following treatments cell lysates were
collected for RNA and protein expression and cell culture supernatants were used for ELISA.
Reverse Transcription and quantitative-PCR (RT-qPCR)
Total RNA from PBMCs, monocytes or macrophages, treated or not, was isolated using the
RNAeasy mini kit (Qiagen) including a DNase step (Qiagen). RNA was reversed transcribed in
the presence of 2.5 mM oligo-dT using the Transcriptor High Fidelity cDNA Synthesis Kit
(Roche), following the manufacturer’s instructions. 5 ng of cDNA was amplified using the
Mesa Blue qPCR MasterMix Plus for SYBR Assay (Eurogentec) in the Light Cycler LC480
(Roche). mRNA expression was normalized to the levels of ribosomal protein L13a, RPL13A
(NM_012423.2), which was used as housekeeping gene. The relative level of expression of a
gene between sample 1 (treated) and sample 2 (control) was calculated using the ΔΔCt formula:
2−(Ct1−Ct RPL13A 1)−(Ct2−Ct RPL13A 2). Normalized Ct values (mean of controls) were used to calcu-
late the gene expression ratio between two samples. Primers (S1 Table) were designed using
the Probe Finder software (http://qpcr.probefinder.com/organism.jsp; Roche Life sciences)
NLRP3 inflammasome activation
Polarized monocytes and macrophages were treated with LPS 100 ng/ml for 3, 7 or 24 h. In
order to induce NLRP3 inflammasome activation, cells were additionally stimulated with 5
mM of adenosine triphosphate (ATP) (Sigma Aldrich) for the last 30 minutes. Supernatants
were collected and stored at -20˚C for cytokine measurement by ELISA.
Western blot analysis
PBMCs, monocytes or macrophages were lysed in (5×) Laemmli SDS buffer supplemented
with 1% β-mercaptoethanol, 0.01% bromophenol blue and protease inhibitor cocktail (Roche).
Equal amounts of protein were analyzed by SDS-PAGE. Proteins were transferred to PVDF
membranes and incubated with primary and secondary antibodies following the manufactur-
ers’ instructions. Primary antibodies against ASC (1:2000, AL177), caspase-1 (1:1000, Bally-1)
and NLRP3 (1:1000, Cryo-2) were from Adipogen. Anti-IL-1β (1:500, AF201) antibody was
from R&D. Anti-GAPDH and anti-Actin antibodies (1:5000) were from Cell Signaling. Sec-
ondary HRP-linked antibodies against rabbit and mouse IgG (1:2000) were from Cell Signal-
ing and against goat IgG (1:2000) was from R&D. Immunoblots were revealed using the
enhanced chemiluminescence reagent (Thermo Scientific) and visualized using a BIORAD
camera (Universal Hood II). GAPDH or Actin was used as loading controls.
ELISA
Cell culture supernatants from human monocytes and macrophages were collected after treat-
ments, centrifuged for 10 minutes at 250×g and kept at -20˚C for cytokine measurements. IL-
NLR expression in polarized monocytes and macrophages
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1α, IL-1β, IL-1ra, and TNF-α were quantified using the DuoSet ELISA kits (R&D). For IL18,
we used the human IL18 ELISA kit (MBL). All measurements were made following manufac-
turers’ instructions.
Statistics
Results are presented as the mean ± standard error of the mean (SEM) from experiments per-
formed in duplicate in cells from at least 4 independent donors. The Mann Whitney was used
to evaluate the statistical significance of differences between 2 groups. A value of P<0.05 was
considered significant. GraphPad Prism software was used for data organization, analysis and
graphing.
Results
Expression of NLRs, caspases and cytokines in human PBMCs,
monocytes and macrophages
We initially studied the mRNA expression of different NLR genes in human PBMC, mono-
cytes and macrophages. As shown in Fig 1A, the expression of NLRP1, NLRP3, NLRP6 and
NOD2, which is already low in PBMC (Ct >28), is further decreased during differentiation
of adherent monocytes to macrophages. The opposite happens with NLRP2 and NLRC4 and
NLRP12 whose expression is induced from PBMCs to monocytes and macrophages
Fig 1. NLR expression in human PBMCs, monocytes and macrophages. (A) mRNA gene expression was measured by RT-qPCR and presented
as relative fold change of PBMCs. Data represent the mean ± standard error of the mean (SEM) of 4 experiments performed in duplicate in cells
isolated from 4 independent donors. Mono: monocytes; Macro: macrophages. Asterisks indicate significant differences as compared to PBMCs
(Mann Whitney test: * p < 0.05; ** p < 0.01). (B) Western blot analysis in total lysates of human PBMCs, monocytes and macrophages using anti-
NLRP3 antibody. GAPDH was used as loading control. The blot shown is representative of at least 5 experiments from independent donors. Mono:
monocytes; Macro: macrophages.
https://doi.org/10.1371/journal.pone.0175336.g001
NLR expression in polarized monocytes and macrophages
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(Fig 1A). The expression of MRC1, a marker of monocyte differentiation to macrophages, is
accordingly induced. The gene expression of CASP1, CASP3, CASP4 and ASC is increased
in monocytes and macrophages as compared to PBMCs, but does not change significantly
between monocytes and macrophages (Fig 2A). The mRNA expression of IL1A and IL1B
decreases from PBMCs to monocytes and to macrophages, whereas IL18 expression is low
in PBMCs and monocytes (Ct >30) but increases in macrophages. IL6 mRNA expression
does not change significantly between PBMCs, monocytes and macrophages, whereas the
expression TNF is induced in monocytes as compared to PBMCs and macrophages
(Fig 2A).
We then tested the protein expression of NLRP3 inflammasome components in PBMCs,
monocytes and macrophages. NLRP3 protein expression was found to vary among donors but
Fig 2. CASP and cytokine expression in human PBMCs, monocytes and macrophages. (A) mRNA gene expression was measured by RT-qPCR
and expressed as relative fold change of PBMCs. Data represent the mean ± SEM of 4 experiments performed in duplicate in cells isolated from 4
independent donors. Asterisks indicate significant differences as compared to PBMCs (Mann Whitney test: * p < 0.05; ** p < 0.01; *** p < 0.001); (#)
indicates significant differences between monocytes and macrophages (Mann Whitney test: # p < 0.05). (B&C) Western blot analysis in total lysates
from human PBMCs, monocytes and macrophages using an anti-ASC, an anti-caspase-1 or an anti-IL-1β antibody. GAPDH was used as loading
control. Western blots are representative of at least 5 independent experiments. Mono: monocytes; Macro: macrophages; casp-1: caspase-1.
https://doi.org/10.1371/journal.pone.0175336.g002
NLR expression in polarized monocytes and macrophages
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detectable most times in PBMCs, monocytes and macrophages. One major band was detected
around 120 kDa, corresponding to the expected molecular weight, and some strong potentially
non-specific bands appeared in lower molecular weights (Fig 1B and data not shown). ASC
protein expression followed the gene expression pattern and was found to be up-regulated in
monocytes and macrophages as compared to PBMCs (Fig 2B). Several bands were detected in
PBMCs including pro-caspase-1, the zymogen form of caspase-1, and a fragment at about 20
KDa, which correspond to the p20 active form of caspase-1. Mainly the pro-caspase-1 was
detected in monocytes and macrophages (Fig 2C). As expected, without stimulation, pro-IL-
1β the inactive form of IL-1β, was hardly detectable in PBMCs, monocytes and macrophages
(Fig 2B).
Expression of NLRs, caspases and cytokines in human monocytes
polarized towards a M1 or M2 phenotype in the presence or absence of
LPS
We next studied the gene expression of NLRs in polarized monocytes in the presence or
absence of LPS, a common stimulus used for inflammasome activation. Polarization mark-
ers CXCL10 for M1 and ALOX15 for M2 were significantly up-regulated in the respective
phenotypes (S2 Fig -upper panel). The expression of NLRP1 was down-regulated in M2
monocytes in the presence or absence of LPS (Fig 3), but this result did not reach statistical
significance, as the expression levels of NLRP1 were already low in M0 monocytes. Expres-
sion of NLRP2 and NLRP6 was low (Ct >30) and was not affected by polarization or LPS
treatment (Fig 3). NLRP3 expression was low in M0, M1 and M2 monocytes. Most impor-
tantly, LPS significantly induced NLRP3 expression in M0 and M1 cells, but in M2 mono-
cytes, there was either lack or an inhibition of the induction. NLRC4 expression was not
modulated by polarization but in the presence of LPS in the M2 cells, the expression was sig-
nificantly decreased. NLRP12 was slightly increased in the M2 monocytes as compared to
M0 or M1 cells and was not significantly modulated by LPS. NOD2 expression was strongly
up-regulated in M1 cells and this result was not dependent on the presence or absence of
LPS. In summary, the expression of NLRs is low in M0 human adherent monocytes. Among
the NLRs tested, only the gene expression of NOD2 was significantly induced in M1 cells,
whereas LPS differentially modulated the expression of NLRP3 and NLRC4 between M1 and
M2 cells.
Inflammasome-related CASP1 and CASP4 mRNA expression was strongly up-regulated in
M1 monocytes and in the presence of LPS, this result was more pronounced (Fig 3). Effector
CASP3 gene expression was not modulated by monocyte polarization. ASC expression was not
modulated by monocyte polarization, but in the presence of LPS, there was a significant
decrease in all conditions (M0, M1, and M2). mRNA expression of IL1A and IL1B was slightly
up-regulated in the presence of INF-γ (M1 cells) (Ct 27 and Ct33 respectively), and signif-
icantly increased (more that 1000-fold) in the presence of LPS. In M0 and M1 cells, the effect
of LPS was stronger as compared to M2 monocytes. IL6 mRNA was significantly increased
(more than 2000-fold) in the presence of LPS and this effect was stronger in M1 cells (Fig 3).
IL18 mRNA was low in M0 (Ct <30) and M1 (Ct<31) monocytes, as compared to IL1B and
significantly lower in M2 cells (Ct< 32). In the presence of LPS, a small 2 to 3-fold increase in
IL18 mRNA was observed in M0 and M1 cells; the increase was less important in M2 mono-
cytes. TNF mRNA was up-regulated in the presence of IFN-γ. In the presence of LPS, the
expression was increased more than 200 times in all conditions and this effect was more obvi-
ous in M1 monocytes.
NLR expression in polarized monocytes and macrophages
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NLRP3 inflammasome protein expression in polarized monocytes
Similar to gene expression, NLRP3 protein expression was significantly up-regulated in the
presence of LPS in M0 or M1 monocytes, whereas in M2 monocytes, there was lack or inhibi-
tion of NLRP3 induction (Fig 4A), underscoring the importance of the local microenviron-
ment on NLRP3 expression. ASC protein expression was detectable in M0, M1 or M2
monocytes and was not significantly modulated by LPS (Fig 4A). Protein expression of pro-
caspase-1 (45 kDa) was very strong under all conditions. A band corresponding to the molecu-
lar weight of the cleaved caspase-1 (p20) was apparent in all conditions but the intensity of the
band was weaker in the M2 cells in the presence or absence of LPS (Fig 4A). Following the
gene expression pattern, pro-IL-1β was strongly expressed in M1 but was almost absent in M2
monocytes. Treatment with LPS strongly induced the protein expression in all conditions. Sev-
eral low molecular bands, including one corresponding to the molecular weight of the active
Fig 3. NLR, CASP and cytokine gene expression in human polarized monocytes. Monocytes were polarized towards M1 or M2 and
stimulated with 100 ng/ml LPS for 3h as described in the methods. mRNA was isolated and gene expression was measured by RT-qPCR
and expressed as relative fold change of M0. Data represent the mean ± SEM of 4 experiments performed in duplicates in cells isolated
from 4 independent donors. M0: cells treated with complete medium (control); M1: cells treated with 100 ng/ml IFN-γ (polarized towards
M1); M2: cells treated with 10 ng/ml IL-4+IL-13 (polarized towards M2). Asterisks indicate significant differences as compared to M0 (Mann
Whitney test: * p < 0.05; ** p < 0.01); (#) points out significant differences between the indicated groups (Mann Whitney test: # p < 0.05; ##
p < 0.01).
https://doi.org/10.1371/journal.pone.0175336.g003
NLR expression in polarized monocytes and macrophages
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form (17 kDa), was present in M0, M1 or M2 monocytes after treatment with LPS (Fig 4A)
suggesting inflammasome activation.
Cytokine secretion during NLRP3-dependent inflammasome activation
in human polarized monocytes
We then tested cytokine secretion during NLRP3 inflammasome activation in M0, M1 or M2
cells using time-dependent-LPS priming and exogenous ATP during the last 30 minutes [29–
31]. Inflammasome-dependent IL-1β secretion started after a 3h treatment with LPS and ATP,
whereas in the presence of LPS alone, IL-1β secretion was detected after a 24h treatment, indi-
cating the importance of the two signals for robust activation of inflammasome in human
monocytes (Fig 4B). These results were similar in M0, M1 and M2 cells; however, in M2
monocytes, IL-1β secretion was lower at all-time points. Interestingly, a 24h treatment with
Fig 4. NLRP3 inflammasome protein expression in polarized monocytes. (A) Western blot analysis from total cell lysates of M0, M1 or
M2 monocytes in the presence or absence of LPS using an anti-NLRP3, an anti-ASC, an anti-caspase-1 or an anti-IL-1β antibody. GAPDH
was used as loading control. Blots are representative of 3 independent experiments. (B-D) IL-1β, IL-1α and IL-18 secretion as assessed
by ELISA in cell culture supernatants of M0, M1, or M2 monocytes after activation of NLRP3 inflammasome with 100 ng/ml LPS for the
indicated time in the presence or absence of 5mM ATP for the last 30 minutes. M0: cells treated with complete medium (control); M1: cells
treated with 100 ng/ml IFN-γ (polarized towards M1); M2: cells treated with 10 ng/ml IL-4+IL-13 (polarized towards M2). Data represent the
mean ± SEM of 4 independent experiments done in monocytes isolated from buffy coats of 4 independent donors.
https://doi.org/10.1371/journal.pone.0175336.g004
NLR expression in polarized monocytes and macrophages
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LPS only slightly increased IL-18 secretion, which was generally very low in M0, M1 or M2
cells (Fig 4C). Addition of ATP had a marginal if any impact in M0 or M1 monocytes. In M2
cells, the secretion was very low at all-time points (Fig 4C). IL-1α, which can be secreted by
caspase-1- dependent and independent pathways [32,33], was secreted only after 24h incuba-
tion with LPS, whereas the secretion started at 7h in the presence of ATP in M1 but not in M0
or M2 cells (Fig 4D). Neither time-dependent exposure to LPS nor ATP had an impact on IL-
1ra secretion, which remained higher in M2 monocytes as compared to M1 or to M0 cells (S3
Fig). TNF-α secretion, which is not modulated by the inflammasome, started after 3h incuba-
tion with LPS, whereas addition of ATP as expected had no additional impact. TNF-α secre-
tion remained lower in M2 monocytes as compared to M0 or M1 in all conditions (S3 Fig).
These results indicate that the local microenvironment impacts the activation of the inflamma-
some and thus the regulation of IL-1β secretion. The secretion profile of inflammasome-regu-
lated IL-18 and the kinetics of IL-1α secretion are of particular interest and potentially
highlight the different roles these cytokines may play as alarmins under different inflammatory
environments.
Expression of NLRs, caspases and cytokines in human macrophages
polarized towards a M1 or M2 phenotype in the presence or absence of
LPS
Polarization markers, CXCL10 for M1 and ALOX15 for M2, were significantly up-regulated in
the respective phenotypes as shown in S2 Fig -lower panel. The expression of NLRP1, NLRP2
and NLRP6 and NLRP12 was low (Ct>30) and was not significantly modulated during macro-
phage polarization in the presence or absence of LPS. NLRP3 was up-regulated in the presence
of LPS and interestingly, this effect was stronger in M1 macrophages, whereas there was lack
or inhibition of induction in M2 macrophages, similar to what we saw in monocytes. NLRC4
(Ct<28 before LPS treatment) expression was down-regulated by LPS (Ct<29 after LPS treat-
ment), an effect seen mainly in M2 macrophages. NOD2 was significantly up-regulated in M1
macrophages in the presence or absence of LPS. Similarly to what we observed in monocytes,
the expression of inflammasome-related CASP1 and CASP4 was significantly up-regulated in
M1 macrophages and treatment with LPS further induced this effect. CASP3 mRNA was
induced 2-fold in M1 macrophages treated with LPS. ASC mRNA expression was not affected
by the polarization status and a minor decrease was seen in the presence of LPS (Fig 5).
The polarization status only slightly induced the mRNA expression of IL1B, IL6 and TNF.
In the presence of LPS, their mRNA levels were increased more than a thousand-fold in M0
and M1 macrophages. IL18 and IL1A mRNA levels were also significantly induced by LPS, but
to a much lesser extent than what observed with IL1B, IL6, TNF (Fig 5). In M2 cells, in the
presence of LPS, there was an inhibition of the cytokine gene expression (Fig 5).
NLRP3 inflammasome protein expression in polarized macrophages
NLRP3 protein expression in macrophages followed the mRNA expression and was up-regu-
lated in the presence of LPS in M0 or M1 macrophages but not in M2 (Fig 6A). In the presence
of LPS, ASC protein expression was not significantly modulated. The zymogen form of pro-
caspase-1 (45 kDa) was present in all conditions, whereas the cleaved form was not detected
(Fig 6A). This result is in line with the hypothesis that macrophages need two signals for
inflammasome activation: LPS, which induces the mRNA expression of IL1B and NLRP3, and
a second signal which induces the autoproteolytic cleavage of pro-caspase-1 [32]. Similar to
caspase-1, only the pro-form of IL-1β was detected in LPS-treated macrophages, although
NLR expression in polarized monocytes and macrophages
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several fragmented forms were present probably due to the very strong expression of the
zymogen form. In the absence of LPS, pro-IL-1β expression was lower in M2 macrophages
(Fig 6A).
Cytokine secretion in human polarized macrophages during
NLRP3-dependent inflammasome activation
LPS alone induced a low IL-1β secretion after 7h incubation in M0, M1 and M2 cells, whereas
in the presence of ATP, the secretion of IL-1β was higher and started after 3h. In M2 macro-
phages, the IL-1β secretion was lower than in M1 or M0 cells (Fig 6B). IL-18 secretion was
very low and was not increased by treatment with ATP (Fig 6C). IL-1α secretion increased
only after 24h incubation with LPS in M0, M1 or M2 cells, whereas the presence of ATP
induced a small secretion of IL-1α in M0 and M1 cells (Fig 6D). IL-1ra was not affected by
Fig 5. NLR, CASP and cytokine gene expression in human polarized macrophages. Monocyte derived macrophages were polarized
towards M1, M2, or M0 and stimulated with 100 ng/ml LPS for 3h as described in the methods. mRNA was isolated and gene expression
was measured by RT-qPCR and expressed as relative fold change of M0. Data represent the mean ± SEM of 4 experiments performed in
duplicates in cells isolated from independent donors. M0: cells treated with complete medium (control); M1: cells treated with 100 ng/ml IFN-
γ (polarized towards M1); M2: cells treated with 10 ng/ml IL-4+IL-13 (polarized towards M2). Asterisks indicate significant differences as
compared to M0 (Mann Whitney test: * p < 0.05, ** p < 0.01); (#) points out significant differences between the indicated groups (Mann
Whitney test: # p < 0.05; ## p < 0.01).
https://doi.org/10.1371/journal.pone.0175336.g005
NLR expression in polarized monocytes and macrophages
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treatment with LPS or ATP, and secretion levels were higher in M2 macrophages (S4 Fig). LPS
induced TNF-α secretion in a time-dependent manner, whereas ATP had no effect. TNF-α
secretion was lower in M2 cells (S4 Fig).
Discussion
Although the importance of inflammasomes in host defense and in many inflammatory and
metabolic diseases is established [10,11,23,24], the majority of the experimental data has come
from work in mice, or from overexpression systems in human cell lines that are not relevant to
innate immunity [33–36]. In the current study, we used human primary monocytes and
monocyte-derived macrophages to study inflammasome gene expression. Despite being intra-
cellular complexes, inflammasomes regulate secretion of the IL-1 family of pro-inflammatory
cytokines, thereby defining the immediate environment of the host cell. Monocytes and
Fig 6. NLRP3 inflammasome protein expression in polarized macrophages. (A) Western blot analysis from total cell lysates of M0, M1
or M2 macrophages in the presence or absence of LPS using an anti-NLRP3, an anti-ASC, an anti-caspase-1 or an anti-IL-1β antibody.
GAPDH was used as loading control. Blots are representative of 3 independent experiments. (B-D) IL-1β, IL-1α and IL-18 secretion as
assessed by ELISA in cell culture supernatants of M0, M1, or M2 monocytes after activation of NLRP3 inflammasome with 100 ng/ml LPS
for the indicated period of times in the presence or absence of 5mM ATP for the last 30 minutes. M0: cells treated with complete medium
(control); M1: cells treated with 100 ng/ml IFN-γ (polarized towards M1); M2: cells treated with 10 ng/ml IL-4+IL-13 (polarized towards M2).
Data represent the mean ± SEM of 4 independent experiments done in macrophages derived from monocytes of 4 independent donors.
https://doi.org/10.1371/journal.pone.0175336.g006
NLR expression in polarized monocytes and macrophages
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macrophages adapt to their surrounding conditions by phenotypic polarization towards pro-
inflammatory M1 or anti-inflammatory M2 phenotype that display opposing activities. M1
cells promote inflammation, whereas M2 cells are critical for inflammation resolution. Here,
we provide data on the expression of several NLR family members, caspases and cytokines in
human polarized monocytes and monocyte-derived macrophages (M1/M2 phenotypes) before
and after activation by LPS [16,32].
The plasticity of macrophages has been described in vivo in different pathophysiological
conditions [37]. The polarization phenotype indicate that under specific conditions in their
microenvironment, pro- or anti- inflammatory responses (associated with M1 & M2 pheno-
types, respectively) dominate at any given time point. In other words, genes tested in M1 and
M2 polarized cells will be expressed in both types of cells. But a specific stimulus (e.g., patho-
gen) will commonly up-regulate sets of anti-inflammatory genes in M2 cells, which are
“primed” for resolution of inflammation, whereas in M1 “primed” cells, the same set of genes
will be down-regulated. We tested whether or not polarization of human monocytes and mac-
rophages impacts activation of inflammasome in the most relevant in vitro environment.
Under basal conditions in monocytes and macrophages, NLR expression is low, whereas a
pro-inflammatory environment (i.e., IFN-γ treatment leading to M1 phenotype) induces only
the expression of NOD2, suggesting that increased IFN-γ levels in the local environment is not
a triggering factor for all NLRs.
Microbial patterns (PAMPs) are sensed by specific NLRs. The effect of LPS induced specifi-
cally the expression of NLRP3, in line with previously reported results in human monocytes
and macrophages [38,39] and is potentially NF-κB-dependent [40]. However, in M2 cells (i.e.,
polarization with IL-4, IL13), the effect of LPS in inducing NLRP3 expression was inhibited
and this is one of the important results of this study. Although many different PAMPs and
DAMPs activate NLRP3 inflammasome, the molecular mechanisms governing NLRP3 expres-
sion and activation still remain puzzling. The impact of LPS on NLRP3 expression can be
either at the transcriptional level, or, during shorter incubation periods, LPS can induce
NLRP3 deubiquitination leading to inflammasome activation [41]. In our system, the effect of
LPS in M1 cells seems to be at the transcriptional level, whereas in M2 cells, a potential impact
of LPS on NLRP3 ubiquitination cannot be excluded and is worth further investigation. Very
few molecules are known to down-regulate NLRP3 expression at both mRNA and protein lev-
els [42,43]. In the murine Nlrp3 promoter, aryl hydrocarbon receptor binding sites have been
identified suggesting that several exogenous and endogenous ligands can act as repressors of
Nlrp3 transcription [42]. Tight regulation of NLRP3 is critical for inflammatory outcome, and
anti-inflammatory conditions (M2 phenotype) assure that the NLRP3 inflammasome is not
activated. One would therefore expect that an M1 monocyte/macrophage phenotype prevails
in inflammatory diseases associated with NLRP3 mutations, but this remains to be addressed.
Although basal levels of CASP1, CASP3 and CASP4 are present in PBMCs, their expression
was found to be up-regulated in monocytes and macrophages. Interestingly, IFN-γ (M1 stimu-
lus) specifically induced the mRNA of the inflammasome-assembling caspases CASP1 and
CASP4 but not CASP3. Caspase 1 is considered as a canonical inflammasome partner, whereas
caspase 4 is mainly described as part of a non-canonical inflammasome as it can directly bind
intracellular LPS and regulate cytokine secretion [44]. These results correlated with an
increased presence of the active form of caspase-1 in lysates of M1 monocytes. Additionally, in
M1 monocytes, pro-inflammatory cytokine expression was induced. The NLRP3 inflamma-
some is commonly activated after receiving a priming signal from LPS through TLR4 and a
second signal from a variety of PAMPs or DAMPs including from purinergic receptors in
response to ATP [45,46]. The effect of NF-κB-dependent LPS modulation of cytokine mRNA
expression was important in all cytokines apart from IL18. Inflammasome-dependent IL-1β
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secretion in monocytes was seen only after 24h incubation with LPS, whereas IL-1α and IL-18
secretion was very modest even after lengthy incubations. The presence of ATP, accelerated
the kinetics of IL-1β and IL-1α and marginally IL-18 secretion, but had no effect on TNF-α or
IL-1ra, which do not depend on the inflammasome.
M0, M1 or M2 macrophages, like monocytes, showed a similar regulation of NLR, caspase
and cytokine mRNA expression, which suggests that monocytes, the first cells to encounter
PAMPs and/or DAMPs, rapidly adapt to the environmental conditions by regulating the
expression of inflammasome genes. These “acquired characteristics” are retained during
monocyte migration to tissues and differentiation into resident macrophages. However, in
macrophages, we were not able to detect the active form of the caspase-1, regardless of the
polarization status of the cells. This result is in accordance with secreted IL-1β levels in macro-
phages which, even after lengthy treatments with LPS were almost 10 times lower as compared
to monocytes. Although ATP induced IL-1β secretion in M0, M1 and to a lesser extend in M2
macrophages, the secretion levels were still very low compared to those seen in monocytes. IL-
18 was marginally influenced by the presence of LPS at both mRNA and secreted protein lev-
els. ATP had no additional effect on IL-18 secretion in macrophages. IL-18 is considered as an
inflammasome-regulated cytokine [10] but our results suggest that its modulation is not simi-
lar to that of IL-1β, and additional pathways may regulate its levels. In contrast, IL-1α regula-
tion in M1 or M2 macrophages is very similar to that of IL-1β in the conditions tested. In
agreement with recent studies [47–49], this result supports the idea that IL-1α levels may also
be regulated through inflammasome. Whether IL-1α secretion is a caspase-1 or caspase-4
-dependent inflammasome worth further studies. Its secretion should thus be measured in
plasma or cell supernatants in order to better understand its role in inflammatory diseases.
In our study, secretion of all tested cytokines was lower in M2 as compared to M1 mono-
cytes apart from IL-1ra, an anti-inflammatory cytokine [50] whose levels were constantly
higher in M2 cells in all conditions tested. These results are in agreement with a previous study
showing that the effect of E.coli and ion channel receptor P2X7R on NLRP3 inflammasome
activation is different in M1 as compared to M2 macrophages [51]. In addition, the authors
showed that release of IL-1β may be an extracellular stimulus for monocyte and macrophage
polarization.
In our study, we also compared expression levels among PBMCs, human monocytes and
monocyte-derived macrophages. We used PBMCs because these cells are easily accessible
from patients’ blood and are commonly used in inflammasome-related studies (e.g., [35,52–
54]). Monocytes were then enriched from PBMCs, through an adherence step. We observed
that, for some NLRs, the mRNA expression levels were higher in PBMCs than in monocytes.
Several hypotheses can explain this observation. First of all, the basal levels of the majority of
the NLRs are low (28–35 Ct). As PBMCs are a heterogeneous population, which contain cells
from myeloid and lymphoid origin, one cannot exclude that, during the isolation of PBMCs
from total blood, a few polymorphonuclear cells may persist, which also express inflamma-
some genes [55]. Subtle differences due to the presence of polymorphonuclear cells may
impact the NLR expression and explain the differences seen between PBMCs and monocytes
(i.e., NLRP1, NOD2). Secondly, we observed that NLR expression is modulated by adherence
(from PBMCs to monocytes) and by the differentiation of monocytes into macrophages. The
fact that the adherence, which implies cytoskeleton changes, impacts NLR expression is not
surprising, as several studies showed that mechanistic links exist between NLRs and cytoskele-
ton [56].
The simultaneous expression of different NLRs in the same cell suggests that interactions
among NLRs may exist at the protein level. Such interactions are possible through homotypic
domain interactions [57]. In that line, Salmonella infection has recently been shown to induce
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recruitment of both NLRP3 and NLRC4 to the same inflammasome complex along with ASC,
caspase-1, and caspase-8 [58,59]. NLR expression is not redundant and depends on the differ-
entiation state of the mononuclear cells. It would be thus interesting to understand the role of
each NLR in different immune cell types in basal or disease conditions.
In conclusion, this study provides extensive data on gene and protein expression of several
NLR and NLRP3 inflammasome-related components under pro- or anti-inflammatory condi-
tions in relevant human primary cells. Understanding inflammasome gene expression and reg-
ulation will help better take in charge inflammatory conditions. Recent work has shown that
elevated and persistent expression of inflammasome genes in older individuals is associated
with all causes of mortality [60]. Our results underline that at a given time and under a given
stimulus, cells modulate their expression to adapt to the environment. The data obtained
clearly show that NLRP3 expression is negatively regulated under M2 conditions, a result that
can open new avenues of research and new ways of regulating the activation of the NLRP3
inflammasome.
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with 100 ng/ml LPS for the indicated time in the presence or absence of 5mM ATP for the last
30 minutes. M0: cells treated with complete medium (control); M1: cells treated with 100 ng/
ml IFN-γ (polarized towards M1); M2: cells treated with 10 ng/ml IL-4+IL-13 (polarized
towards M2). Data represent the mean ± SEM of 4 independent experiments done in mono-
cytes isolated from buffy coats of 4 independent donors.
(PDF)
S4 Fig. Pro-inflammatory cytokine secretion after NLRP3 inflammasome activation in
polarized macrophages. IL-1ra and TNF-α secretion as assessed by ELISA in cell culture
supernatants of M0, M1, or M2 monocytes after activation of NLRP3 inflammasome with 100
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